At this time, posts about Naivek are rapidly increasing on portals and stock communities, with foreigners tentatively recorded as net buying 5,133 shares today. Naivek is known as a manufacturer of biomaterials for tissue regeneration and oral health products.
As of 1:30 PM on the 2nd, Naivek's stock price is 37,150 KRW, up 2.62% from the previous day, with a trading volume of 159,062 shares, which is about 30.75% of the 5-day average trading volume. On February 24th, Naivek was a market issue due to the news of 'European CRO validation for pulmonary fibrosis treatment.'
In addition to Naivek, posts by investors are also surging for GtreeBNT (115450), Gooyoung Tech (053270), and SGA Solutions (184230).

※Source: AI Investment Assistant AI Rassi
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
